Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
出版年份 2014 全文链接
标题
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 13, Issue 9, Pages 673-691
出版商
Springer Nature
发表日期
2014-08-18
DOI
10.1038/nrd4360
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
- (2014) M. Bots et al. BLOOD
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Chromatin Remodeling as a Molecular Basis for the Enhanced Functionality of Memory CD8 T Cells
- (2014) J. K. Northrop et al. JOURNAL OF IMMUNOLOGY
- The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies
- (2014) K. L. Rice et al. JOURNAL OF INTERNAL MEDICINE
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
- (2014) I-N Hsieh et al. Cell Death & Disease
- Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
- (2014) Maj-Linda Selenica et al. Alzheimers Research & Therapy
- Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
- (2013) David J. Irwin et al. AMERICAN JOURNAL OF PATHOLOGY
- Spinal muscular atrophy: An update on therapeutic progress
- (2013) Joonbae Seo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity
- (2013) Abhijit Saha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a small molecular compound simultaneously targeting RXR and HADC: Design, synthesis, molecular docking and bioassay
- (2013) Guo-Liang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dual-acting histone deacetylase-topoisomerase I inhibitors
- (2013) William Guerrant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function
- (2013) M. R. Heideman et al. BLOOD
- Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice
- (2013) O. M. Dovey et al. BLOOD
- A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
- (2013) F. Santoro et al. BLOOD
- A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
- (2013) M Kaliszczak et al. BRITISH JOURNAL OF CANCER
- A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies
- (2013) Gert J. Ossenkoppele et al. BRITISH JOURNAL OF HAEMATOLOGY
- An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
- (2013) A. C. West et al. CANCER RESEARCH
- A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
- (2013) M New et al. CELL DEATH AND DIFFERENTIATION
- A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
- (2013) Hitisha K. Patel et al. ChemMedChem
- Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
- (2013) Tianzhu Qiu et al. Future Oncology
- Genetic syndromes caused by mutations in epigenetic genes
- (2013) María Berdasco et al. HUMAN GENETICS
- Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
- (2013) Casey Cook et al. HUMAN MOLECULAR GENETICS
- Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects
- (2013) Santosh Vishwakarma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages
- (2013) Melanie R. Shakespear et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation
- (2013) Amel Dudakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity
- (2013) Berkley E. Gryder et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment
- (2013) Jhih-Bin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
- (2013) David E. Olson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease
- (2013) Chao-Wu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
- (2013) J Minami et al. LEUKEMIA
- Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities
- (2013) A. Newbold et al. MOLECULAR CANCER THERAPEUTICS
- Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
- (2013) Claudia Simões-Pires et al. Molecular Neurodegeneration
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
- (2013) Lihong Shi et al. NATURE MEDICINE
- Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
- (2013) Jeanine Jochems et al. NEUROPSYCHOPHARMACOLOGY
- Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
- (2013) Christina E. Wells et al. PLoS One
- A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests
- (2013) Frederick A. Schroeder et al. PLoS One
- HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
- (2013) M. Malvaez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of the CoREST/REST Repressor Complex in Herpes Simplex Virus 1 Productive Infection and in Latency
- (2013) Guoying Zhou et al. Viruses-Basel
- HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses
- (2013) J E Bolden et al. Cell Death & Disease
- Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance
- (2013) D Dupéré-Richer et al. Cell Death & Disease
- Development of a Chimeric c-Src Kinase and HDAC Inhibitor
- (2013) Kristin S. Ko et al. ACS Medicinal Chemistry Letters
- HDAC7 Is a Repressor of Myeloid Genes Whose Downregulation Is Required for Transdifferentiation of Pre-B Cells into Macrophages
- (2013) Bruna Barneda-Zahonero et al. PLoS Genetics
- The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
- (2013) Hanne Fredly et al. Clinical Epigenetics
- Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs
- (2013) Melissa D. Cantley et al. INFLAMMOPHARMACOLOGY
- HDAC inhibitor therapy in autoimmunity and transplantation
- (2012) Wayne W Hancock et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Histone/protein deacetylases and T-cell immune responses
- (2012) T. Akimova et al. BLOOD
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential
- (2012) W.-J. Shia et al. BLOOD
- Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
- (2012) Xinwei Zhang et al. CANCER CELL
- Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
- (2012) E. Pazolli et al. CANCER RESEARCH
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma
- (2012) Donna M. Weber et al. Clinical Lymphoma Myeloma & Leukemia
- Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
- (2012) T. Ai et al. CURRENT MEDICINAL CHEMISTRY
- Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
- (2012) Praveer Gupta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
- (2012) Nambirajan Govindarajan et al. EMBO Molecular Medicine
- Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
- (2012) Dominica Willmann et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
- (2012) Young Ju Lee et al. International Journal of Medical Sciences
- Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
- (2012) Elisabetta Soragni et al. JOURNAL OF CHILD NEUROLOGY
- Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2012) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
- (2012) Winnie Yeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
- (2012) Takayoshi Suzuki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
- (2012) William Guerrant et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Essential Role for Histone Deacetylase 4 in Synaptic Plasticity and Memory Formation
- (2012) M.-S. Kim et al. JOURNAL OF NEUROSCIENCE
- Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL
- (2012) M Leiva et al. LEUKEMIA
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Trials with ‘epigenetic’ drugs: An update
- (2012) Angela Nebbioso et al. Molecular Oncology
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- An epigenetic blockade of cognitive functions in the neurodegenerating brain
- (2012) Johannes Gräff et al. NATURE
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
- (2012) Haiqun Jia et al. NEUROBIOLOGY OF DISEASE
- Targeting Epigenetic Readers in Cancer
- (2012) Mark A. Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Studies of YK-4-272, an Inhibitor of Class II Histone Deacetylases by Disruption of Nucleocytoplasmic Shuttling
- (2012) Hye-Sik Kong et al. PHARMACEUTICAL RESEARCH
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice
- (2012) Masahide Fukada et al. PLoS One
- Cell Cycle Regulation by the PRMT6 Arginine Methyltransferase through Repression of Cyclin-Dependent Kinase Inhibitors
- (2012) Markus A. Kleinschmidt et al. PLoS One
- Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors
- (2012) H. S. Bandukwala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
- (2012) N. Gammoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- (2012) Wenyu Yu et al. Nature Communications
- Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
- (2012) Geneviève P Delcuve et al. Clinical Epigenetics
- Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
- (2012) Li Shen et al. OncoImmunology
- Differential regulation of the SMN2 gene by individual HDAC proteins
- (2011) Matthew C. Evans et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Revisiting the differentiation paradigm in acute promyelocytic leukemia
- (2011) J. Ablain et al. BLOOD
- Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents
- (2011) S. K. Ghosh et al. BLOOD
- Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines
- (2011) Indra Sari Kusuma Harahap et al. BRAIN & DEVELOPMENT
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
- (2011) Zhi-Qiang Ning et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
- (2011) B. E. Schwartz et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
- (2011) T. Nguyen et al. CLINICAL CANCER RESEARCH
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice
- (2011) Deborah Y. Kwon et al. HUMAN MOLECULAR GENETICS
- HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation
- (2011) Matthew J Sweet et al. IMMUNOLOGY AND CELL BIOLOGY
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Efficacy of Antidepressants for Late-Life Depression
- (2011) Enrico Tedeschini et al. JOURNAL OF CLINICAL PSYCHIATRY
- Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
- (2011) D J P M Stumpel et al. LEUKEMIA
- Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor
- (2011) Wenjuan Yu et al. LEUKEMIA RESEARCH
- Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
- (2011) E. F. de Zoeten et al. MOLECULAR AND CELLULAR BIOLOGY
- Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo
- (2011) G. Dasmahapatra et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Leo Joosten et al. MOLECULAR MEDICINE
- HDACs link the DNA damage response, processing of double-strand breaks and autophagy
- (2011) Thomas Robert et al. NATURE
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes
- (2011) Maria N Navarro et al. NATURE IMMUNOLOGY
- Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
- (2011) Chiranjeevi Sandi et al. NEUROBIOLOGY OF DISEASE
- Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
- (2011) Anna Bobrowska et al. PLoS One
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease
- (2011) J. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies
- (2011) A. J. Christiansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- The acetylation of tau inhibits its function and promotes pathological tau aggregation
- (2011) Todd J. Cohen et al. Nature Communications
- Haploinsufficiency of HDAC4 Causes Brachydactyly Mental Retardation Syndrome, with Brachydactyly Type E, Developmental Delays, and Behavioral Problems
- (2010) Stephen R. Williams et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids
- (2010) Marc Lamblin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound -phenylethyl isothiocyanate
- (2010) Y. Hu et al. BLOOD
- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
- (2010) Srividya Bhaskara et al. CANCER CELL
- Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions
- (2010) Mareike Schmudde et al. CANCER LETTERS
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
- (2010) Cheng-Jung Lai et al. CANCER RESEARCH
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- Effects of a novel arginine methyltransferase inhibitor on T-helper cell cytokine production
- (2010) Kevin Bonham et al. FEBS Journal
- Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
- (2010) T. Yamaguchi et al. GENES & DEVELOPMENT
- Antitumor activities and on-target toxicities mediated by a TRAIL receptor agonist following cotreatment with panobinostat
- (2010) Ben P. Martin et al. INTERNATIONAL JOURNAL OF CANCER
- Conditional Deletion of Histone Deacetylase 1 in T Cells Leads to Enhanced Airway Inflammation and Increased Th2 Cytokine Production
- (2010) R. Grausenburger et al. JOURNAL OF IMMUNOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells
- (2010) W Song et al. LEUKEMIA
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects
- (2010) G M Marshall et al. ONCOGENE
- Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
- (2010) Sushant K. Kachhap et al. PLoS One
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
- (2010) O. Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic regulation of CD8+ T-lymphocyte mediated suppression of HIV-1 replication
- (2010) Kevin O. Saunders et al. VIROLOGY
- Histone deacetylase inhibitors and HIV latency
- (2010) David M Margolis Current Opinion in HIV and AIDS
- Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
- (2009) Nancie M Archin et al. AIDS
- Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors
- (2009) Pierre Tessier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CBF is critical for AML1-ETO and TEL-AML1 activity
- (2009) L. Roudaia et al. BLOOD
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis
- (2009) Susan Fotheringham et al. CANCER CELL
- Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
- (2009) Hyunkyung Jeong et al. CELL
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- Rational Combinations Using HDAC Inhibitors
- (2009) M. Bots et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors In Inflammatory Disease
- (2009) Maria Halili et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
- (2009) Edwin F. de Zoeten et al. GASTROENTEROLOGY
- A phosphorylation-acetylation switch regulates STAT1 signaling
- (2009) O. H. Kramer et al. GENES & DEVELOPMENT
- Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
- (2009) D. Ritchie et al. HAEMATOLOGICA
- Histone Deacetylases 1 and 2 Form a Developmental Switch That Controls Excitatory Synapse Maturation and Function
- (2009) M. W. Akhtar et al. JOURNAL OF NEUROSCIENCE
- HDAC2 negatively regulates memory formation and synaptic plasticity
- (2009) Ji-Song Guan et al. NATURE
- Histone deacetylases and the immunological network: implications in cancer and inflammation
- (2009) A Villagra et al. ONCOGENE
- Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development
- (2009) R. L. Montgomery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
- (2008) K. F. Whitecross et al. BLOOD
- Targeting tumor angiogenesis with histone deacetylase inhibitors
- (2008) Leigh Ellis et al. CANCER LETTERS
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
- (2008) V. R. Fantin et al. CANCER RESEARCH
- HDAC4 inhibits cell-cycle progression and protects neurons from cell death
- (2008) Nazanin Majdzadeh et al. Developmental Neurobiology
- Transcriptional Modulation Using HDACi Depsipeptide Promotes Immune Cell-Mediated Tumor Destruction of Murine B16 Melanoma
- (2008) Takashi Murakami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pulse Inhibition of Histone Deacetylases Induces Complete Resistance to Oxidative Death in Cortical Neurons without Toxicity and Reveals a Role for Cytoplasmic p21waf1/cip1 in Cell Cycle-Independent Neuroprotection
- (2008) B. Langley et al. JOURNAL OF NEUROSCIENCE
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- Histone Deacetylase 5 Acquires Calcium/Calmodulin-Dependent Kinase II Responsiveness by Oligomerization with Histone Deacetylase 4
- (2008) J. Backs et al. MOLECULAR AND CELLULAR BIOLOGY
- Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
- (2008) A. Newbold et al. MOLECULAR CANCER THERAPEUTICS
- The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
- (2008) Alejandro Villagra et al. NATURE IMMUNOLOGY
- Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
- (2008) Dohoon Kim et al. NEURON
- HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
- (2008) Myriam Rai et al. PLoS One
- Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist
- (2008) L. E. Tavera-Mendoza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
- (2008) A. J. Frew et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Class IIA HDACs in the regulation of neurodegeneration
- (2007) Nazanin Majdzadeh Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started